Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SWISX vs. IDEV: which is better?

Bottom line

SWISX vs IDEV: the short answer

SWISX (Schwab International Index Fund) and IDEV (iShares Core MSCI International Developed Markets ETF) share a meaningful slice of their top holdings — about 75% by weight.

But IDEV is far broader, holding 2,337 positions to 697 for SWISX, so beyond the top names it adds exposure SWISX doesn't have.

IDEV is cheaper at 0.04% vs 0.06% — a difference of $2.00 a year per $10,000 invested.

Over five years, SWISX returned +9.0% a year vs +5.0% for IDEV (reporting dates differ).

Updated Nov 19, 2026

SWISX vs IDEV side by side

SWISXIDEV
TypeMutual fundETF
Fund familySchwabiShares
CategoryInternational StockInternational Stock
Expense ratio0.06%0.04%
Annual cost per $10k$6$4
10-yr cost on $10k (prospectus)$77$51
Max front load—None
12b-1 fee—0%
1-yr return+31.6%+4.5%
5-yr return (annualized)+9.0%+5.0%
10-yr return (annualized)+8.3%—
Best quarter+18.2%+16.9%
Worst quarter−23.2%−24.0%
Net assets (fund)$13.6B$31.6B
Number of holdings6972,337
Portfolio turnover1%3%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSWISXIDEVDifference
2024+3.5%+4.5%−1.0%
2023+18.2%+17.3%+0.9%
2022−14.3%−14.9%+0.7%
2021+11.3%+12.7%−1.4%
2020+8.1%+8.4%−0.3%
2019+21.9%+23.4%−1.5%
2018−13.3%−14.3%+1.0%

Source: Fund prospectus bar charts

Holdings overlap

17 of SWISX's top 25 holdings also appear in IDEV's top 25.

Shared top holdings
HoldingSWISXIDEV
ASML Holding NV2.58%2.19%
Roche Holding AG1.48%1.05%
HSBC Holdings PLC1.41%1.24%
AstraZeneca PLC1.34%0.88%
Novartis AG1.30%0.98%
Nestle SA1.14%0.88%
Shell PLC1.03%0.88%
Sap Se0.96%0.65%
Mitsubishi UFJ Financial Group Inc0.96%0.82%
Banco Santander SA0.88%0.70%
Commonwealth Bank of Australia0.80%0.72%
Allianz SE0.79%0.65%
Schneider Electric SE0.73%0.63%
UBS Group AG0.70%0.57%
Banco Bilbao Vizcaya Argentaria SA0.68%0.54%

Source: SEC Form N-PORT

SWISX top 10

  1. ASML Holding NV — 2.58%
  2. Roche Holding AG — 1.48%
  3. HSBC Holdings PLC — 1.41%
  4. AstraZeneca PLC — 1.34%
  5. Novartis AG — 1.30%
  6. Nestle SA — 1.14%
  7. Siemens AG — 1.06%
  8. Shell PLC — 1.03%
  9. Toyota Motor Corp — 0.99%
  10. Sap Se — 0.96%

IDEV top 10

  1. ASML Holding N.V. — 2.19%
  2. Hsbc Holdings Plc — 1.24%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
  4. Roche Holding AG — 1.05%
  5. Royal Bank Of Canada — 1.00%
  6. Novartis AG — 0.98%
  7. Astrazeneca Plc — 0.88%
  8. Nestle S.A. — 0.88%
  9. Shell Plc — 0.88%
  10. Siemens Aktiengesellschaft — 0.83%

FAQ

What is the difference between SWISX and IDEV?
SWISX (Schwab International Index Fund) and IDEV (iShares Core MSCI International Developed Markets ETF) share a meaningful slice of their top holdings — about 75% by weight. But IDEV is far broader, holding 2,337 positions to 697 for SWISX, so beyond the top names it adds exposure SWISX doesn't have.
Which is cheaper, SWISX or IDEV?
IDEV has the lower expense ratio (0.04%).
Should I own both SWISX and IDEV?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.